Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Breast Cancer

  Free Subscription


Articles published in Pathology

Retrieve available abstracts of 14 articles:
HTML format



Single Articles


    December 2020
  1. KAWASAKI T, Kaira K, Nakamura Y, Imai H, et al
    Re: INSM1 is a novel prognostic neuroedocrine marker for luminal B breast cancer.
    Pathology. 2020 Dec 29. pii: S0031-3025(20)31009.
    PubMed    


  2. RAZVI H, Tsang JY, Tse GM
    Re: INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer: author reply.
    Pathology. 2020 Dec 28. pii: S0031-3025(20)31010.
    PubMed    


    September 2020
  3. RAZVI H, Tsang JY, Poon IK, Chan SK, et al
    INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer.
    Pathology. 2020 Sep 17. pii: S0031-3025(20)30888.
    PubMed     Abstract available


    June 2020
  4. FUCHS TL, Pearson A, Pickett J, Diakos C, et al
    Why pathologists and oncologists should know about tumour-infiltrating lymphocytes (TILs) in triple-negative breast cancer: an Australian experience of 139 cases.
    Pathology. 2020 Jun 14. pii: S0031-3025(20)30822.
    PubMed     Abstract available


    April 2020
  5. MACNEIL JAB, Selegean S, Williams AS
    Metastatic lobular carcinoma presenting as retroperitoneal fibrosis: a rare presentation detected using post-mortem cytology.
    Pathology. 2020;52:387-390.
    PubMed    


    February 2020
  6. RHODES A, Teoh KH, See MH, Ganesan K, et al
    Breast cancer hormone receptor testing in Asia: is it time to think again on expected positivity rates and methods of scoring?
    Pathology. 2020 Feb 24. pii: S0031-3025(20)30709.
    PubMed    


  7. XU Z, Shen W, Pan A, Sun F, et al
    Decreased Nek9 expression correlates with aggressive behaviour and predicts unfavourable prognosis in breast cancer.
    Pathology. 2020 Feb 22. pii: S0031-3025(20)30458.
    PubMed     Abstract available


    June 2019
  8. LIEN HC, Lee YH, Juang YL, Lu YT, et al
    Fibrillin-1, a novel TGF-beta-induced factor, is preferentially expressed in metaplastic carcinoma with spindle sarcomatous metaplasia.
    Pathology. 2019;51:375-383.
    PubMed     Abstract available


    May 2019
  9. FARSHID G, Bilous M, Morey A, Fox S, et al
    ASCO/CAP 2018 breast cancer HER2 testing guidelines: summary of pertinent recommendations for practice in Australia.
    Pathology. 2019 May 7. pii: S0031-3025(18)30615.
    PubMed     Abstract available


    April 2019
  10. WANG M, McLaren S, Jeyathevan R, Allanson BM, et al
    Laboratory validation studies in Ki-67 digital image analysis of breast carcinoma: a pathway to routine quality assurance.
    Pathology. 2019;51:246-252.
    PubMed     Abstract available


  11. ZABOROWSKI M, Pearson A, Sioson L, Gill AJ, et al
    Androgen receptor immunoexpression in triple-negative breast cancers: is it a prognostic factor?
    Pathology. 2019;51:327-329.
    PubMed    


  12. DESSAUVAGIE BF, Thomas C, Robinson C, Harvey J, et al
    Digital evaluation of proliferative 'hotspots' of more than 16,000 cells negatively impacts Ki-67 assessment in breast carcinoma.
    Pathology. 2019;51:329-331.
    PubMed    


    August 2018
  13. ABDULLGAFFAR B, Raman L
    Spontaneous breast haematoma in a woman with Bernard-Soulier giant platelet disorder.
    Pathology. 2018;50:578-580.
    PubMed    


    April 2018
  14. LIM JCT, Yeong JPS, Lim CJ, Ong CCH, et al
    An automated staining protocol for seven-colour immunofluorescence of human tissue sections for diagnostic and prognostic use.
    Pathology. 2018;50:333-341.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: